missing translation for 'onlineSavingsMsg'
Learn More

Occludin Antibody (rOCLN/8525), Novus Biologicals™

Mouse Monoclonal Antibody

€ 250.00 - € 494.00

Specifications

Antigen Occludin
Clone rOCLN/8525
Concentration 0.2 mg/ml
Dilution Immunohistochemistry-Paraffin 1-2 μg/mL
Applications Immunohistochemistry (Paraffin)
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18630894
View Documents Promotion Details
Novus Biologicals
NBP3-20356-20ug
20 μg
€ 250.00
20µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
18616914
View Documents
Novus Biologicals
NBP3-20356-100ug
100 μg
€ 494.00
100µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Occludin Monoclonal antibody specifically detects Occludin in Human samples. It is validated for Immunohistochemistry (Paraffin)
Specifications

Specifications

Occludin
0.2 mg/ml
Immunohistochemistry (Paraffin)
Unconjugated
Mouse
Signal Transduction
10mM PBS with 0.05% BSA
100506658
IgG1 κ
Protein A or G purified
rOCLN/8525
Immunohistochemistry-Paraffin 1-2 μg/mL
Monoclonal
Purified
RUO
Human
BLCPMG, occludin
Recombinant human Occludin fragment around aa 282-415 (Exact sequence is proprietary)
Primary
Store at 4&drg;C. Do not freeze.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.